New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
11:59 EDTISRG, NVDQ, SYKIntuitive Surgical climbs after new surgical system debuts
Shares of surgical instrument and accessory maker Intuitive Surgical (ISRG) are climbing after the company announced the FDA cleared the U.S introduction of its new da Vinci Xi Surgical System. WHAT'S NEW: Intuitive Surgical introduced the da Vinci Xi Surgical System, which it says has broader capabilities than prior generations of its prior generation da Vinci System. Intuitive said it designed the new da Vinci Xi System with the goal of further advancing the technology used in minimally invasive surgery for complex diseases and conditions in gynecology, urology, thoracic, cardiac, and general surgery. ANALYST OPINON: Research firm Leerink sees today's news as a positive for Intuitive Surgical, but said it is uncertain exactly how many incremental system sales the da Vinci XI Surgical system will fuel and whether the features of Intuitive's new robot will lead to increased utilization into new surgery areas. The firm keeps the stock at a Market Perform rating. JPMorgan responded to the news by raising its price target on Intuitive Surgical to $500 from $475. JPMorgan said it views the new system as a significant positive that has the potential to both drive a replacement cycle and further increase penetration and utilization of the company's products within hospitals. PRICE ACTION: Near midday, shares of Intuitive Surgical were up about $39, or 8.9%, to $477. OTHERS TO WATCH: Novadaq (NVDQ), which sells consoles for Intuitive Surgical's robotic systems, rose 2.2% to $22.77. Shares of Stryker (SYK), which previously acquired robotic surgery systems maker MAKO Surgical, were little changed near noon.
News For ISRG;NVDQ;SYK From The Last 14 Days
Check below for free stories on ISRG;NVDQ;SYK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 22, 2014
17:00 EDTISRGIntuitive Surgical narrows FY14 procedure growth view to 5%-8% from 2%-8%
Subscribe for More Information
16:57 EDTISRGIntuitive Surgical sees international procedure growth 'lumpy' QoQ
Subscribe for More Information
16:39 EDTISRGIntuitive Surgical sees capital pressures in most hospitals to continue
Subscribe for More Information
16:17 EDTISRGIntuitive Surgical reports Q2 adjusted EPS $3.73, GAAP EPS $2.77
Consensus $2.83. Intuitive Surgical ended Q2 with $2B in cash, cash equivalents, and investments, a decrease of $920M during the quarter, primarily reflecting the impact of $1B utilized during the quarter to repurchase shares of its common stock.
16:13 EDTISRGIntuitive Surgical rises after results, first look
Subscribe for More Information
16:06 EDTISRGIntuitive Surgical reports Q2 EPS $2.77, consensus $2.83
Subscribe for More Information
15:30 EDTISRGNotable companies reporting after market close
Subscribe for More Information
13:57 EDTISRGEarnings Preview: Intuitive Surgical share price flat over last 12 months
Subscribe for More Information
11:36 EDTISRGIntuitive Surgical July weekly volatility increases into Q2 and outlook
Subscribe for More Information
08:36 EDTSYKStryker appoints CEO Kevin Lobo as chairman
Subscribe for More Information
July 18, 2014
09:00 EDTSYKStryker price target raised to $92 from $87 at RW Baird
Baird raised its price target on Stryker to $92 from $87 citing valuation, organic sales growth, and solid risk/reward. The firm has an Outperform rating on the stock.
07:37 EDTISRGIntuitive Surgical Q2 expectations 'appear achievable,' says Jefferies
Jefferies says its hospital and surgeon channel checks increase its comfort level around initial Xi demand and overall placements ahead of Intuitive Surgical's Q2 results, though the firm cautions that visibility on utilization is low and procedures could come in below consensus. Jefferies thinks expectations for Q2 "appear achievable" since they incorporate near-term challenges. The firm keeps a Buy rating on the stock with a $465 price target.
July 17, 2014
16:09 EDTSYKStryker sees Q3 adjusted EPS $1.12-$1.16 , consensus $1.16
"If foreign currency exchange rates hold near current levels, we do not expect the impact on third quarter or full year net sales to be significant," the company said.
16:08 EDTSYKStryker sees FY14 adjusted EPS $4.75-$4.80, consensus $4.80
Now projecting full year organic sales growth to be in the range of 5.0%-6.0%, consensus $9.61B.
16:07 EDTSYKStryker reports Q2 adjusted EPS $1.08, consensus $1.08
Subscribe for More Information
15:26 EDTSYKNotable companies reporting after market close
Subscribe for More Information
July 15, 2014
07:18 EDTNVDQNovadaq has strong products, improved sales team, says Stifel
Subscribe for More Information
July 10, 2014
14:29 EDTISRGT. Rowe Price reports 11.1% passive stake in Intuitive Surgical
Subscribe for More Information
06:42 EDTSYKBiomet reports Q4 net sales up 7.7% to $844.5M
Subscribe for More Information
06:05 EDTISRGIntuitive Surgical survey shows growing Japan momentum, says Jefferies
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use